Skip to main content
. 2008 Sep 22;52(11):4023–4029. doi: 10.1128/AAC.00707-08

TABLE 2.

Epidemiological data, MBL determinants, clonal lineages, and resistance phenotypes for the MBL-producing isolates

Isolatea Specimen Wardh Enzyme Clone Integronb MICc (μg/ml) of:
PIP TZP CAZ FEP ATM IMP MEM COL AMK GEN CIP LEV
TO-16X-51 Urine ICU VIM-1 NAd NA >128 >128 >128 128 8 4 2 0.25 24 2 >32 >32
RM-11X-11 Urine ICU VIM-1 NA NA >128 >128 >128 >128 8 >32 >32 0.25 1 4 0.06 0.25
FG-17X-14 Sputum ICU VIM-1 A1 In70e >128 >128 >128 >128 6 >32 >32 1 8 >128 >32 >32
NA-14X-21 Urine ICU VIM-1 A2 In70 >128 >128 >128 >128 8 >32 >32 2 24 >128 >32 >32
NA-14X-26 Urine ICU VIM-1 A2 NA >128 >128 >128 >128 8 >32 >32 2 32 >128 >32 >32
NA-14X-32 Urine ICU VIM-1 A2 NA >128 >128 >128 >128 6 >32 >32 2 24 >128 >32 >32
NA-14X-34 Urine ICU VIM-1 A3 In70 >128 >128 >128 >128 6 >32 >32 2 24 >128 >32 >32
FG-17X-08 Sputum ICU VIM-1 A3 NA >128 >128 >128 >128 64 >32 >32 0.5 16 >128 >32 >32
VA-06X-69 Urine Nephrology VIM-1 D In110e >128 >128 >128 >128 4 >32 >32 1 8 >128 >32 >32
VA-06X-63 Blood Nephrology VIM-1 D1 NA >128 >128 >128 >128 4 >32 >32 1 8 >128 >32 >32
VA-06X-16 Wound specimen Geriatrics VIM-1 D2 In110 >128 >128 >128 >128 4 >32 >32 1 8 >128 >32 >32
VA-06X-17 Wound specimen Pneumology VIM-1 D2 In110 >128 >128 >128 >128 6 >32 >32 1 8 >128 >32 >32
VA-06X-65 Sputum Pneumology VIM-1 D3 In110 >128 >128 >128 >128 0.25 >32 >32 0.5 8 >128 >32 >32
VA-06X-47 Urine Nephrology VIM-1 D4 In110 >128 >128 >128 >128 4 >32 >32 1 8 >128 >32 >32
VA-06X-29 Pus Otology VIM-1 E In80e >128 >128 >128 >128 8 >32 >32 2 >128 >128 >32 >32
RM-11X-09 Wound specimen ICU VIM-1 F In75f >128 >128 >128 >128 16 >32 >32 1 8 >128 >32 >32
NA-14X-13 Blood ICU VIM-1 G In105e >128 >128 >128 >128 8 >32 >32 2 128 >128 >32 >32
SS-09X-45 Urine Nephrology VIM-2 B1 NAg >128 >128 >128 >128 6 >32 >32 2 128 >128 >32 >32
VA-06X-20 Urine Orthopedics VIM-2 B2 NA 64 48 64 64 8 >32 >32 1 >128 8 >32 >32
VA-06X-28 Blood Geriatrics VIM-2 B2 NA 64 48 64 64 8 >32 >32 1 >128 8 >32 >32
VA-06X-38 Wound specimen Geriatrics VIM-2 B2 In59e 32 32 48 48 4 >32 >32 1 >128 8 >32 >32
CR-04X-14 Blood ICU VIM-2 B3 NA >128 >128 64 64 8 >32 >32 2 >128 8 >32 >32
PV-05X-02 Wound specimen Medicine VIM-2 B3 In59 48 32 32 32 8 >32 8 1 >128 8 >32 >32
PV-05X-07 Vascular catheter specimen Pneumology VIM-2 B3 NA 48 32 32 48 8 >32 8 1 >128 8 >32 >32
AV-13X-28 Urine ICU IMP-13 C1 In88f 24 16 >128 >128 8 16 8 2 8 >128 >32 >32
NA-14X-02 Urine Urology IMP-13 C2 In89f 24 16 >128 >128 16 >32 >32 0.5 16 >128 >32 >32
NA-14X-10 Blood ICU IMP-13 C2 NA 16 16 >128 >128 16 >32 >32 0.5 16 >128 >32 >32
NA-14X-11 Urine Urology IMP-13 C2 NA 16 16 >128 >128 16 >32 >32 0.5 16 >128 >32 >32
NA-14X-12 Urine Urology IMP-13 C2 NA 16 16 >128 >128 16 >32 >32 0.5 16 >128 >32 >32
PG-12X-03 Sputum ICU IMP-13 C3 InPSGe 16 16 >128 >128 16 >32 >32 0.5 >128 >128 >32 >32
a

The first two letters of the name indicate the city of origin (Fig. 1), as follows: TO, Turin; RM, Rome; FG, Foggia; NA, Naples; VA, Varese; SS, Sassari; CR, Cremona; PV, Pavia; AV, Avellino; and PG, Perugia. The first two isolates listed, TO-16X-51 and RM-11X-11, were E. cloacae and P. putida, respectively; all other isolates listed were P. aeruginosa.

b

The structures of the variable regions of class 1 integrons carrying MBL gene cassettes in P. aeruginosa isolates representative of different clonal lineages and variants thereof were determined.

c

Abbreviations for antimicrobial agents: PIP, piperacillin; TZP, piperacillin-tazobactam; CAZ, ceftazidime; FEP, cefepime; ATM, aztreonam; IPM, imipenem; MEM, meropenem; COL, colistin; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; and LEV, levofloxacin.

d

NA, not applicable.

e

Integron detected previously in Italy or France (11, 12, 21, 25, 28, 31).

f

New integron detected in this work.

g

Amplification of the blaVIM-2-containing integron was unsuccessful with this isolate.

h

Ward in which the patient providing the sample was hospitalized. ICU, intensive care unit.